Dr. Stemmer-Rachamimov is an attending pathologist on the Neuropathology and Autopsy services of Pathology, and is a member of the diagnostic staff of the Cogan Laboratory of Ophthalmic Pathology at Massachusetts Eye and Ear Infirmary.
Anat Stemmer-Rachamimov, MD, is a faculty member of the C. S. Kubik Laboratory for Neuropathology. She is associate director of the Cogan Laboratory of Ophthalmic Pathology with Director Frederick A. Jakobiec, MD, at Mass Eye and Ear, providing diagnostic services, instruction to trainees on the Neuropathology service through didactic teaching sessions and routine sign-out procedures. She is a consulting pathologist with the Specialized Histopathology Services Core for DF/HCC investigators.
Her conference activities may include weekly or monthly conferences with Pathology, Neurology and Neuro-Oncology. She has particular interest in weekly consensus review sessions in which all primary brain tumors are discussed, along with cases of complexity or particular interest. This session allows the neuropathology staff to maintain a consistent set of diagnostic criteria and terminology.
She is one of four neuropathologists that diagnose approximately 700 in-house surgical neuropathology cases, and 500 consultation cases per year. In a given year, over 900 intra-operative diagnostic consultations are processed. The surgical Opththalmic Pathology team processes over 1,500 cases per year.
Her research interests focus on identifying the underlying molecular changes in the lesions and malformations associated with hereditary brain tumor syndromes such as neurofibromatosis 1, neurofibromatosis 2, schwannomatosis, and tuberous sclerosis.
Our lab's research focuses on identifying the underlying molecular changes in the lesions and malformations associated with hereditary brain tumor syndromes (neurofibromatosis 1, neurofibromatosis 2, schwannomatosis and tuberous sclerosis), and the identification of activated pathways or events that lead to tumor progression. We are now moving from defining the molecular features and understanding the biology to more practical translational research of biomarkers and drug screens.
See details at the Stemmer-Rachamimov Lab.
Phone 2: 617-726-5156